Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Mel Sorensen Insider Profile
4 Followers
Mel Sorensen, President & CEO, Director at Galera Therapeutics, holds 265.03K shares in Galera Therapeutics (Ticker: GRTX). Most recently, Mel Sorensen Sold $67,015 shares of Galera Therapeutics on Aug 20, 2024 for an estimated value of 4.69K.
Mel Sorensen Galera Therapeutics (GRTX)President & CEO, Director
Galera Therapeutics (GRTX)
President & CEO, Director
Ranked #67,889 out of 99,797 Corporate Insiders
Profitable Transactions
1 out of 2 Profitable Transactions
Average Return
-22.30%
Average return per transaction
Time Frame
Compare to
Insider Roles
President & CEO, Director
Roles that Mel Sorensen holds in companies
Most Profitable Insider Trade
The most profitable trade made by Mel Sorensen
Mel Sorensen's Trading History
List of latest transactions for each holding click on a transaction to see Mel Sorensen's performance on stock
You May Also Like
Mel Sorensen insider profile FAQ
What is the percentage of profitable transactions made by Mel Sorensen?
The percentage of profitable transactions made by Mel Sorensen is 50%.
What is the average return per transaction made by Mel Sorensen?
The average return per transaction made by Mel Sorensen is -22.30%.
What stocks does Mel Sorensen hold?
Mel Sorensen holds: GRTX stocks.
What was Mel Sorensen’s latest transaction?
Mel Sorensen latest transaction was an Informative Sell of $4.69K.
What was Mel Sorensen's most profitable transaction?
Mel Sorensen’s most profitable transaction was an Informative Sell of GRTX stock on August 20, 2024. The return on the trade was 45.30%.
What is Mel Sorensen's role in Galera Therapeutics?
Mel Sorensen's role in Galera Therapeutics is President & CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.